A large and generous collection of artwork donated by the family of the late Marvin Lowe was added to buildings of BIO5 Institute earlier this year.

BIO5 member Christopher Glembotski at University of Arizona College of Medicine-Phoenix is studying the molecular basis of heart disease to develop new treatments. His work, funded by a $2.8M NIH grant, could revolutionize heart disease care globally.

BIO5 members Lalitha Madhavan and Robin Polt are part of a group of researchers who published a study finding that a tiny protein called PNA5 appears to have a protective effect on brain cells, which could lead to treatments for the cognitive symptoms of Parkinson’s disease and related disorders.

The U.S. Army awarded $2.1 million to a team of researchers led by BIO5 member Judith Su to build a handheld version of her record-breaking FLOWER sensing device for active military personnel.

BIO5 member Michael Kuhns and a team of researchers at the U of A Health Sciences Center for Advanced Molecular and Immunological Therapies are investigating the potential of genetically engineered T cells to treat autoimmune diseases

BIO5 members Bruce Tabashnik and Luciano Matzkin in the College of Agriculture, Life and Environmental Sciences used genomics to investigate the genetic changes causing resistance to transgenic crops in field populations of the corn earworm, also known as cotton bollworm.

2021 BIO5 Postdoctoral Fellow Rob Jackson at the University of Arizona College of Medicine - Tucson secured a pivotal National Institutes of Health grant to establish his career in virology and oral cancer.

BIO5 members Floyd "Ski" Chilton and Joel Cuello are collaborating on a project revolving around a blue-green algae-like microorganism known as spirulina that could provide nutrition to people in areas of food insecurity while addressing some of the challenges posed by climate change.

BIO5 member William “Scott” Killgore and his team will use a $3M grant from the Department of Defense to examine a noninvasive, drug-free treatment for sleep disorders.

An Oct. 30 groundbreaking ceremony marked the next step for CAMI, a biomedical research hub to be located on the Phoenix Bioscience Core. BIO5 member Deepta Bhattacharya is the inaugural executive director.